What's breaking now, across thousands of outlets.
The parent of cell therapy maker Gamida Cell will be the lead bidder in a court-supervised auction of Karyopharm, which recently cut a forbearance deal to push off debt payments.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The effort, funded by private donors, seeks to train the model on a trove of MRI and magnetoencephalography data that scientists plan to collect over the next five years—but questions about its…
A new study finds that while dark personality traits and cognitive biases both predict rule-breaking behavior, they do not feed into one another.
Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell…
(MedPage Today) -- Ahead of the American Society of Hematology (ASH) annual meeting, frontline treatment for multiple myeloma continues to evolve, with quadruplet regimens increasingly becoming…
Rx Kids, a program that provides unconditional cash transfers for pregnant people and infants, reduced neonatal mortality in Flint, Michigan.
A defining feature of Alzheimer's disease is the abnormal, sustained accumulation of protein aggregates such as tau inside brain cells, which disrupts the cells' normal functions.
